๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer

โœ Scribed by Y. Yamada; K. Aiba; N. Horikosi; M. Hanai; S. Uno; H. Osawa; N. Mizunuma; S. Takahashi; Y. Ito

Book ID
106285448
Publisher
Springer
Year
2000
Tongue
English
Weight
59 KB
Volume
5
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

An effective low-dose intermittent cyclo
An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer
โœ Richard H. Creech; Robert B. Catalano; Michael J. Mastrangelo; Paul F. Engstrom ๐Ÿ“‚ Article ๐Ÿ“… 1975 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 571 KB

A low-dose, three-drug regimen, C.M.F. (cyclophosphamide 50 mg, P.o., days 1-14; methotrexate, 25 mg, and 5-fluorouracil, 500 mg, i.v., days 1 and 8; cycled every 28 days) was used in 46 consecutive chemotherapy-eligible women (41 previously hormonally treated) with recurrent breast cancer. Thirteen

Continuous infusion of 5-fluorouracil an
Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma
โœ Yong-Suk Chung; Yoshito Yamashita; Tohru Inoue; Tasuku Matsuoka; Bunzo Nakata; N ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB ๐Ÿ‘ 3 views

City Uni-11 cases, for an overall response rate of 50%. Patients with good performance versity Medical School, Osaka, Japan. status (PS) (0-1) and differentiated histologic type showed higher response rates (50.0% and 63.6%, respectively) than patients with poor PS (2 or 3) and undifferenti-2 Insti